Ji-Yun Lee Selected Research

Ji-Yun Lee Research Topics

Disease

8	Inflammation (Inflammations) 01/2021 - 01/2011
5	Neoplasms (Cancer) 10/2021 - 08/2014
4	Asthma (Bronchial Asthma) 01/2022 - 01/2018
4	Pneumonia (Pneumonitis) 01/2022 - 01/2015
2	Stomach Neoplasms (Stomach Cancer) 07/2022 - 09/2012
2	Clonorchiasis 12/2020 - 06/2003
2	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2018
2	Otitis Media 01/2020 - 06/2015
2	Breast Neoplasms (Breast Cancer) 07/2018 - 08/2014
2	Glioma (Gliomas) 05/2018 - 02/2015
2	Infections 01/2011 - 06/2003
2	Alzheimer Disease (Alzheimer's Disease) 06/2009 - 03/2009
1	Necrosis 12/2022
1	Neoplasm Metastasis (Metastasis) 07/2022
1	Neuroinflammatory Diseases 03/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2020
1	Cysts 04/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Cholangiocarcinoma 08/2019
1	Colitis 02/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2018
1	Haemophilus Infections 01/2015
1	Genomic Instability 01/2015
1	Respiratory Syncytial Virus Infections 10/2014
1	Bronchiolitis 10/2014
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 10/2014
1	Acute Promyelocytic Leukemia 09/2014
1	Leukemia 09/2014
1	Carcinogenesis 08/2014
1	Thymus Neoplasms (Thymus Neoplasm) 10/2013
1	Disease Progression 10/2012
1	Adenocarcinoma 09/2012
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 08/2012
1	Adams Oliver syndrome 08/2012
1	Egg Hypersensitivity (Egg Allergy) 03/2010
1	Food Hypersensitivity (Food Allergy) 03/2010
1	Herpes Zoster 02/2010

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 04/2020 - 03/2009
5	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2011
3	OvalbuminIBA 01/2022 - 01/2018
3	vinpocetineIBA 01/2021 - 06/2015
2	MucinsIBA 01/2022 - 06/2015
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2021 - 02/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2003
2	brusatolIBA 01/2021 - 05/2018
2	AntigensIBA 12/2020 - 06/2003
2	Gefitinib (Iressa)FDA Link 01/2020 - 05/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 08/2014
2	Tyrosine Kinase InhibitorsIBA 05/2018 - 10/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 10/2014
2	Deubiquitinating EnzymesIBA 01/2014 - 01/2013
2	Amyloid (Amyloid Fibrils)IBA 06/2009 - 03/2009
2	Peptides (Polypeptides)IBA 03/2009 - 06/2003
1	Malondialdehyde (Propanedial)IBA 12/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2022
1	benzyl isothiocyanateIBA 07/2022
1	Therapeutic UsesIBA 03/2022
1	Interleukin-13IBA 01/2022
1	SandIBA 01/2022
1	3- (N,N- dimethylsulfonamido)- 4- methyl- nitrobenzeneIBA 01/2022
1	Type 7 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 10/2021
1	1-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	ApelinIBA 06/2020
1	Glucose (Dextrose)FDA LinkGeneric 06/2020
1	Complementary DNA (cDNA)IBA 04/2020
1	LipopolysaccharidesIBA 02/2020
1	Genetic Markers (Genetic Marker)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	CytokinesIBA 08/2019
1	sinapinic acidIBA 02/2018
1	cinnamic acidIBA 02/2018
1	AcidsIBA 02/2018
1	Dual Specificity Phosphatase 1IBA 06/2015
1	Emodin (Archin)IBA 02/2015
1	Biological ProductsIBA 02/2015
1	GlucocorticoidsIBA 01/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2015
1	Glycoproteins (Glycoprotein)IBA 10/2014
1	Formaldehyde (Formol)FDA Link 10/2014
1	DNA VaccinesIBA 10/2014
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2014
1	Metformin (Glucophage)FDA LinkGeneric 08/2014
1	Tamoxifen FDA LinkGeneric 08/2014
1	phorbolIBA 08/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	Imatinib Mesylate (Gleevec)FDA Link 10/2013
1	Phosphodiesterase 4 InhibitorsIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 09/2012
1	Histidine (L-Histidine)FDA Link 09/2012
1	Carrier Proteins (Binding Protein)IBA 08/2012
1	Immunoglobulins (Immunoglobulin)IBA 08/2012
1	Transcription Factors (Transcription Factor)IBA 01/2011
1	AllergensIBA 03/2010
1	ImmunosorbentsIBA 06/2003

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2013